A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian study

Stefano Gentileschi, Carla Gaggiano, Francesco Placido, Riccardo Terribili, Laura Cometi, Giuseppe Lopalco, Greta Dipietrangelo, Giacomo Cozzi, Roberto Padoan, Riccardo Bixio, Simone Parisi, Maria Chiara Ditto, Gemma Lepri, Claudia Fabiani, Luca Cantarini, Florenzo Iannone, Roberta Ramonda, Bruno Frediani, Serena Guiducci

Therapeutic Advances in Musculoskeletal Disease

Published online on April 27, 2026

Abstract

Therapeutic Advances in Musculoskeletal Disease, Volume 18, January-December 2026.
Background:The recent availability of infliximab subcutaneous biosimilar in Europe represents a significant advancement in therapeutic delivery. Real-world data regarding the new formulation are still limited.Objectives:To describe subcutaneous infliximab ...